Parnell Pharmaceuticals Holdings Ltd. (PARNF)
OTOTC · Common · CUSIP Q73622104
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for PARNF and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
Q73622104
Market Cap
Small Cap · $101 Million
IPO
6/18/2014 · $10.00/share
Previous Symbol
PARN (changed 12/30/2016)
Business: Parnell Pharmaceuticals Holdings Ltd. is a fully integrated veterinary pharmaceutical company focused on developing, manufacturing and commercializing innovative animal health solutions. Parnell currently markets five products for companion animals and production animals in 14 countries and augments its pharmaceutical products with revolutionary digital technologies – iKAM and mySYNCH. These digital applications are designed to optimize the benefits veterinarians and animal owners can obtain from Parnell's best-in-class products.. Parnell believes its unique combination of pharmaceuticals with cutting edge technology solutions establishes them as a business partner with veterinarians and enhances the quality of life of companion animals and production efficiencies for farmers.

Company Contact

CEO
Robert Joseph
CFO
Brad McCarthy
Headquarters
9401 Indian Creek Parkway, Suite 1170, Overland Park, KS 66210
Phone
913-312-0786 · Toll-Free 800-887-2763
Investor Relations
Erika Vikor · 913-312-0786 · Erika.vikor@parnell.com
General Email
info@parnell.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »